Literature DB >> 7728804

Glycosaminoglycan distribution in atherosclerotic saphenous vein grafts.

M V Marquezini1, C M Strunz, L A Dallan, O M Toledo.   

Abstract

Glycosaminoglycan composition of normal saphenous veins and atherosclerotic saphenous vein grafts is reported. Dermatan sulfate is the main glycosaminoglycan present in both normal saphenous veins and saphenous vein grafts. These tissues also contain chondroitin sulfate and heparan sulfate. Although the total amount of glycosaminoglycans decreased in the grafts (compared with normal saphenous veins), the grafts showed an increase in the relative amounts of dermatan sulfate and chondroitin sulfate. Heparan sulfate was decreased, compared with normal controls. These findings suggest the involvement of blood vessel glycosaminoglycans (not only the arterial glycosaminoglycans) in the process of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728804     DOI: 10.1159/000176860

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

1.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

2.  Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.

Authors:  Emily F McNaughton; Andrew D Eustace; Sophie King; Richard B Sessions; Alasdair Kay; Michele Farris; Robert Broadbridge; Oksana Kehoe; Andreas J Kungl; Jim Middleton
Journal:  J Immunol       Date:  2018-03-23       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.